Early stage and seed financing for biotechnology start-ups: A UK perspective

Abstract

It is a tough climate in which to be raising early stage investment but there is funding available for the very best of British biotechnology. This report outlines several sources of funding that the author has found most relevant to early stage biotechnology companies. The competition for the limited funds is harsh so it is vital that biotechnology entrepreneurs choose the right sources of funding and approach them in the right way. The final section briefly outlines how companies can 'tilt the balance' in their favour and learn to move from just being scientifically convincing to becoming a commercially convincing investment opportunity.